Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)

Clinical trial NCT00757029 · COMPLETED

Trial details

NCT number: NCT00757029
Sponsor: Hallym University Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Methylphenidate Pharmacogenetics

Start date: 2005-10-01
Primary completion: 2008-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.